About
Overview
Management team
Board of directors
Investors
Scientific advisory board
Innovation
Overview
Pipeline
Technology
Clinical trials
Overview
LUCE-1
STELLA
CELESTE
For patients
Overview
Usher 1B
Stargardt
Expanded access
News
Careers
Overview
Corporate values
Recruitment companies
Contact
EN
English
Italiano
Search
News
News
Filter by:
All categories
All categories
Press Release
Publication
All disease areas
All disease areas
Stargardt
Usher 1B
Other
By year:
All years
All years
2026
2025
2024
2023
2022
2021
2019
2014
Reset
01.04.2026
Press Release
Other
AAVantgarde appoints Philip Lao as Senior Vice President Business Development
15.01.2026
Press Release
Usher 1B
AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa
08.01.2026
Press Release
AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference
